Rare variants in the<i> MECP2</i> gene in girls with central precocious puberty: a translational cohort study

Background Identification of genetic causes of central precocious puberty have revealed epigenetic mechanisms as regulators of human pubertal timing. MECP2, an X-linked gene, encodes a chromatin-associated protein with a role in gene transcription. MECP2 loss-of-function mutations usually cause Rett syndrome, a severe neurodevelopmental disorder. Early pubertal development has been shown in several patients with Rett syndrome. The aim of this study was to explore whether MECP2 variants are associated with an idiopathic central precocious puberty phenotype. Methods In this translational cohort study, participants were recruited from seven tertiary centres from five countries (Brazil, Spain, France, the USA, and the UK). Patients with idiopathic central precocious puberty were investigated for rare potentially damaging variants in the MECP2 gene, to assess whether MECP2 might contribute to the cause of central precocious puberty. Inclusion criteria were the development of progressive pubertal signs (Tanner stage 2) before the age of 8 years in girls and 9 years in boys and basal or GnRH-stimulated LH pubertal concentrations. Exclusion criteria were the diagnosis of peripheral precocious puberty and the presence of any recognised cause of central precocious puberty (CNS lesions, known monogenic causes, genetic syndromes, or early exposure to sex steroids). All patients included were followed up at the outpatient clinics of participating academic centres. We used high-throughput sequencing in 133 patients and Sanger sequencing of MECP2 in an additional 271 patients. Hypothalamic expression of Mecp2 and colocalisation with GnRH neurons were determined in mice to show expression of Mecp2 in key nuclei related to pubertal timing regulation. Findings Between Jun 15, 2020, and Jun 15, 2022, 404 patients with idiopathic central precocious puberty (383 [95%] girls and 21 [5%] boys; 261 [65%] sporadic cases and 143 [35%] familial cases from 134 unrelated families) were enrolled and assessed. We identified three rare heterozygous likely damaging coding variants in MECP2 in five girls: a de novo missense variant (Arg97Cys) in two monozygotic twin sisters with central precocious puberty and microcephaly; a de novo missense variant (Ser176Arg) in one girl with sporadic central precocious puberty, obesity, and autism; and an insertion (Ala6_Ala8dup) in two unrelated girls with sporadic central precocious puberty. Additionally, we identified one rare heterozygous 3 & PRIME;UTR MECP2 insertion (36_37insT) in two unrelated girls with sporadic central precocious puberty. None of them manifested Rett syndrome. Mecp2 protein colocalised with GnRH expression in hypothalamic nuclei responsible for GnRH regulation in mice. Interpretation We identified rare MECP2 variants in girls with central precocious puberty, with or without mild neurodevelopmental abnormalities. MECP2 might have a role in the hypothalamic control of human pubertal timing, adding to the evidence of involvement of epigenetic and genetic mechanisms in this crucial biological process.

URI

https://observatorio.fm.usp.br/handle/OPI/55961

Referências

Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160
Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251
Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
[Anonymous], 2023, CLINVAR NM 001110792
Bach S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79268-0
Brand BA, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11070904
Brito VN, 2023, ENDOCR REV, V44, P193, DOI 10.1210/endrev/bnac020
Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252
Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582
Dauber A, 2017, J CLIN ENDOCR METAB, V102, P1557, DOI 10.1210/jc.2016-3677
Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007
Garcia-Rudaz C, 2009, J NEUROENDOCRINOL, V21, P108, DOI 10.1111/j.1365-2826.2008.01812.x
Good KV, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.620859
GWAS Catalog, 2023, GENE MECP2
Hamidi T, 2015, EPIGENOMICS-UK, V7, P247, DOI [10.2217/epi.14.80, 10.2217/EPI.14.80]
Harvey CG, 2007, AM J MED GENET B, V144B, P355, DOI 10.1002/ajmg.b.30425
Huang Q, 2021, INDIAN J ANIM RES, DOI [10.18805/IJAR.B-1264, DOI 10.18805/IJAR.B-1264]
Killian JT, 2014, PEDIATR NEUROL, V51, P769, DOI 10.1016/j.pediatrneurol.2014.08.013
Latronico AC, 2016, LANCET DIABETES ENDO, V4, P265, DOI 10.1016/S2213-8587(15)00380-0
Li CY, 2020, NATL SCI REV, V7, P671, DOI 10.1093/nsr/nwaa023
Lunetta KL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8756
Canton APM, 2021, HUM REPROD, V36, P506, DOI 10.1093/humrep/deaa306
Migeon BR, 2020, GENET MED, V22, P1156, DOI 10.1038/s41436-020-0779-4
Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124
Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705
Rodrigues DC, 2020, HUM MOL GENET, V29, pR90, DOI 10.1093/hmg/ddaa154
Saengkaew T, 2021, EUR J ENDOCRINOL, V185, P617, DOI 10.1530/EJE-21-0387
Stefanelli G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28295
Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109
Xiol C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48385-w
Yang LL, 2021, PHARMAZIE, V76, P559, DOI 10.1691/ph.2021.1747
Zachariah RM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415825

Coleções

Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/18
Artigos e Materiais de Revistas Científicas - LIM/25
Artigos e Materiais de Revistas Científicas - LIM/41
Artigos e Materiais de Revistas Científicas - LIM/42

Carregar mais

Página do item completo